Taking Ozempic and worried about vision loss? This test can help you understand your risk.
Single source Only one publisher in our feeds has reported this so far. Treat details as unconfirmed.
Publisher summary — MarketWatch
Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss.
Read the full story on marketwatch.com
Ledgerline did not write this story. The headline and excerpt come from MarketWatch’s public feed; the full article is on the publisher’s site.